1 / 19

Enzymicals AG: Advanced Biocatalytic Solutions for Innovative Chemistry

Discover Enzymicals AG, a leading biocatalysis company offering customized enzyme solutions for chemical synthesis. Learn about our expert team, cutting-edge research, and state-of-the-art protein engineering capabilities. Join us at our Kick-off meeting on 25.01.2012 to explore partnership opportunities. Visit www.enzymicals.com for more details.

jackson-daugherty
Download Presentation

Enzymicals AG: Advanced Biocatalytic Solutions for Innovative Chemistry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Enzymes . Chemicals . Solutions . NewProt Kick-off meeting: 25.01.2012 Partner profileEnzymicals AG Dr. Rainer Wardenga www.enzymicals.com

  2. Company Info Start-up history Spin off from the Institute of Biochemistry at the University of Greifswald Founded in August 2009 as corporation Management Dr. Ulf Menyes (CEO) Dr. Rainer Wardenga (CSO) Supervisory Board Prof. UweBornscheuer (Chairman) Dr. Dagmar Braun Dr. Jürgen Eck Ownership structure Shareholders and strategic investor Northern Germany, Biotechnikum Greifswald 1 www.enzymicals.com

  3. Company Info Start-up history Spin off from the Institute of Biochemistry at the University of Greifswald Founded in August 2009 as corporation Management Dr. Ulf Menyes (CEO) Dr. Rainer Wardenga (CSO) Supervisory Board Prof. Uwe Bornscheuer (Chairman) Dr. Dagmar Braun Dr. Jürgen Eck Ownership structure Shareholders and strategic investor Northern Germany, Sinetific Campus Greifswald 1 www.enzymicals.com

  4. Company Info Management and staff Dr. U. Menyes (Chemist), CEO Dr. R. Wardenga (Biologist and Biotechnologist), CSO Dipl. S. Weber (Economist), finance and controlling Biotechnologists (main focus molecular biology) Biotechnologist (main focus biocatalysis) Chemical technical assistant Biological technical assistant Company management Scientific staff 2 www.enzymicals.com

  5. Company Info Business Segments 3 www.enzymicals.com

  6. Partners Institute of Biochemistry at the University of Greifswald (Prof. Bornscheuer) B.R.A.I.N. AG HERBRAND PharmaChemicals GmbH Institute of Chemistry at the University of Rostock (Prof. Kragl) Institute of Marine Biotechnology e.V. Greifswald 4 www.enzymicals.com

  7. Research & Development Along the Value Chain Core competence in protein science and development of biocatalytic process 5 www.enzymicals.com

  8. Research & Development Along the Value Chain Identification of suitable catalysts Method development and routine application of HPLC, CE, GC and GC-MS Design and application of spectrophotometric assays Synthesis of screening substrates Screening of enzymes or strain collections Search in literature or pathway databases Search of known or novel motives in sequence databases Amplification of novel genes from genomic DNA De-novo genome sequencing and analysis 6 www.enzymicals.com

  9. Research & Development Along the Value Chain Cloning, expression and purification Fully equipped molecular laboratories State of the art expertise in molecular cloning Huge repertoire of expression vectors Well-founded knowledge of a range of recombinant expression systems Approved solutions for proteins which are difficult to express Screening of refolding conditions for aggregated proteins Production capacity up to 30 L-scale Catalysts are available in different grades of purity Purification via affinity-chromatography or fusion-tags 7 www.enzymicals.com

  10. Research & Development Along the Value Chain Cloning, expression and purification in collaboration with B.R.A.I.N AG Production Systems: • Peptide and Protein Production in • Escherichia coli / Bacillus sp. • Pseudomonas stutzeri / Pichia pastoris • Streptomyces sp. • Aspergillus sp. Optimized Production of Peptides or Proteins in Industrial Scale 8 www.enzymicals.com

  11. Research & Development Along the Value Chain Biochemical, physiochemical and structural characterization Determination of catalytic properties and kinetic parameters Characteristics in temperature- and pH-profiles Investigation of storage and process stability Properties via gel-electrophoresis and blotting Secondary structure via CD-spectrophotometry Screening for crystallization conditions via commercial kits Access to MALDI-TOF, 2D-gel-electrophoresis General immobilization studies 9 www.enzymicals.com

  12. Research & Development Along the Value Chain Protein engineering Selection of best engineering approaches for designated targets Approaches often inspired by structural alignments or molecular modeling Homology-model construction and hot-spot identification Rational design of variants by site-directed mutagenesis Directed evolution with high quality variant libraries Selection assays and library screening with high-throughput systems HT-screening of mutant-libraries Access to 3-laser flow cytometer with cell sorter 10 www.enzymicals.com

  13. Research & Development Along the Value Chain Application of best catalysts paired with optimized chemistry Innovative synthetic routes using organic synthesis and biotransformation Custom manufacturing of fine and special chemicals up to the multi-kg scale Catalysis in multi-phase systems or ionic liquids Membrane processes for catalyst recovery and downstream processing 11 www.enzymicals.com

  14. Research & Development Along the Value Chain Application of best catalysts paired with optimized chemistry Innovative synthetic routes using organic synthesis and biotransformation Custom manufacturing of fine and special chemicals up to the multi-kg scale Catalysis in multi-phase systems or ionic liquids Membrane processes for catalyst recovery and downstream processing Scope of our biocatalytic tollbox 12 www.enzymicals.com

  15. NewProt:Objectives (R)-selective amine-transaminases Catalyze the transfer an amino group from a primary amine to a prochiral ketone or aldehyde Usable for the resolution of racemic amines or the synthesis of chiral amines Pyridoxal-5‘-phosphate dependent Typical amines : alanine, ethylamine, 1- and 2-propylamine, 1- and 2-butylamine …. 13 www.enzymicals.com

  16. NewProt: Objectives (R)-selective amine-transaminases Catalytic tool box for the evaluation of synthesis routes Conversion of aliphatic, arylaliphatic and aromatic ketones with strict (R)-selectivity pH-optima range between 7.0 and 8.5 Alanine serves as amine donor Products obtained by asymmetric synthesis with ECS-ATA01-07. 14 www.enzymicals.com

  17. NewProt: Objectives Baeyer-Villigermonooxygenases Flavoenzymes from the class of oxidoreductases Oxidation of linear, cyclic and aromatic ketones to esters or lactones Usable with cofactor regeneration or as whole cell system Known applications: Biooxidation of functionalized cycloketones Biooxidation of bicyclic ketones or chiral b-substituted cycloketones Kinetic resolution of racemic a-substituted cycloketones Regiodivergentbiooxidation of fused bicyclobutanones 15 www.enzymicals.com

  18. NewProt: Objectives Baeyer-Villigermonooxygenases Catalytic tool box for the evaluation of synthesis routes Baeyer-Villiger oxidation of aromatic and aliphatic ketones, able to perform sulfur oxidations High regio- and enantioselectivity, NAD(P)H-dependent Scope of the ECS biooxidation-toolbox. Examples of products obtained from the corresponding ketones with ECS-M01-07. 16 www.enzymicals.com

  19. Thank you for your attention Enzymicals AG , Walther-Rathenau-Straße 49a 17489 Greifswald Fon: +49(0)3834 515-47-0 Fax: +49(0)3834 515-47-3 www.enzymicals.com

More Related